期刊文献+

培美曲塞结合奈达铂治疗老年晚期肺腺癌患者的效果及不良反应 被引量:2

下载PDF
导出
摘要 目的对培美曲塞结合奈达铂治疗老年晚期肺腺癌患者的效果及不良反应进行分析,探讨其临床应用价值。方法 80例老年晚期肺腺癌患者,按照数字抽签法分为实验组和对照组,每组40例。对照组患者采取吉西他滨联合奈达铂治疗,实验组采取培美曲塞联合奈达铂治疗。治疗结束后对比分析两组患者的治疗总有效率和不良反应。结果实验组总有效率为90.00%,对照组总有效率为67.50%,比较差异有统计学意义(P<0.05);实验组不良反应发生3例,对照组13例,比较差异有统计学意义(P<0.05)。结论培美曲塞联合奈达铂治疗可减少老年晚期肺腺癌患者的不良反应情况,提高患者的治疗效果,改善患者的病情,值得在临床中推广和应用。
作者 吕桂萍
出处 《中国现代药物应用》 2015年第24期107-108,共2页 Chinese Journal of Modern Drug Application
  • 相关文献

参考文献5

二级参考文献43

  • 1李树婷,马飞,孙燕.抗肿瘤代谢新药——培美曲塞[J].癌症进展,2005,3(5):471-476. 被引量:73
  • 2Gridelli C,Perrone F,Monfardini S. Lung cancer in the elderly [J].Eur J Cancer, 1997,33:2313-2314. 被引量:1
  • 3Hensing TA,Peterman AH,Schell MJ,et al. The impact of age on toxicity,response rate,quality Of life,and survival in patients with advanced stage m B or Ⅳ nonsmall cell lung carcinoma treated with carboplatin and paclitaxel [J]. Cancer,2003,98: 779-788. 被引量:1
  • 4Gridelli C,Ardizzoni A,Ciardiello F,et al. Second-line treatment of advanced non-small cell lung cancer [J]. J Thorac Oneol, 2008,3:430-440. 被引量:1
  • 5Han K,Cao W,Che J,et al. First line chemotherapy with weeklydoeetaxel and eisplatin in elderly patients with advanced non- small cell lung cancer:a muhicenter phase Ⅱ study[J]. J Thorac Oncol, 2009,4 : 512-517. 被引量:1
  • 6Scagliotti GV,Parikh P,von Pawel J ,et al. Phase Ⅲ study com- paring cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small- cell lung cancer[J]. J Clin Oncol,2008,26:3543-3551. 被引量:1
  • 7Yang CH,Simms L,Park K. Efficacy and safety of cisplatin/ pemetrexed versus cisplatin/gemcitabine as first-line treatment in east asian patients with advanced non-small cell lung cancer:re- suits of an exploratory subgroup analysis of a phase Ⅲ trial[J]. J Thorac Oncol, 2010,5 : 688-695. 被引量:1
  • 8汤钊猷.现代肿瘤学[M].3版.上海:复旦大学出版社,2011:890-931. 被引量:79
  • 9Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011,61 (2) : 69 -90. 被引量:1
  • 10Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer [J]. N Engl J ned,2002,346(2) : 92 -98. 被引量:1

共引文献61

同被引文献29

  • 1段惠洁,顾国民,王秀丽,刘春玲.培美曲塞联合奈达铂一线方案治疗晚期肺腺癌的临床研究[J].肿瘤防治研究,2014,41(1):61-64. 被引量:19
  • 2谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:118-119. 被引量:1253
  • 3王爱娇.中青年和中老年患者的宫颈癌病理特点分析[J].中国农村卫生,2014,12(z2):412-413. 被引量:2
  • 4Siegel R,Naishadham D ,Jemal A. Cancer statistics [J].CA Cancer J Clin,2012,62(1 ) : 10-29. 被引量:1
  • 5Foley G,Alston R, Geraci M,et al. Increasing rates of cervical can- cer in young women in England: an analysis of national data 1982-2006[J].Br J Cancer,2011,105(1 ) : 177-178. 被引量:1
  • 6Luciani S, Cabanes A ,Prieto-Lara E ,et al. Cervical and female breast cancers in the Americas:current situation and opportunities for action[J]. Bull World Health Organ, 2013,91 (9) : 640-649. 被引量:1
  • 7Frumovitz M,Querleu D, Gil-Moreno A,et al. Lumpectomy in Lo- cally Advanced Cervical Cancer Study (LILACS): Phase m Clinical Trial Comparing Surgical With Radio logic Staging in Patients With Stages IB2-IVA Cervical Cancer[J].Journal of Mini- mally Invasive Gynecology, 2014,21 ( 1 ) : 3-8. 被引量:1
  • 8Micheletti E,IaFace B,Bianehi E,et al. Continuous infusion of carboplatin during conventional radiotherapy treatment inad- vanced squamous carcinoma of the cervix uteri 11 B-111 B (UICC) : a phase [ /]] and pharmaceutic study[J]. Am J Clin Oncol,2011, 20(6) :613-620. 被引量:1
  • 9Xiong Y, Liang LZ, Cao LP, et al. Clinical effects of irinotecan hydrochloride in combination with cisplatin as neoadjuvant chemo- therapy in locally advanced cervical cancer[J]. Gynecol Oncol, 2011,123(1):99-104. 被引量:1
  • 10Saslow D,Solomon D,Lawson HW,et al. American Cancer Soci- ety,American Society for Colposcopy and Cervical Pathology,and American Society for Clinical Pathology Screening guidelines for the prevention and early detection of cervical cancer[J]. CA Can- cer J Clin,2012,62(3) : 147-172. 被引量:1

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部